STEVEN LARSEN: Open Payments
NPI 1962562603 · WEST JORDAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,210 in 158 payments from 26 companies in 2025. Trend: 2023 $2,620 · 2024 $2,925 · 2025 $3,210
Food & beverage: $3,210
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $824 |
| PFIZER INC. | 26 | $467 |
| Amgen Inc. | 25 | $314 |
| ABBVIE INC. | 15 | $214 |
| Alkermes, Inc. | 9 | $179 |
| Otsuka America Pharmaceutical, Inc. | 13 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $156 |
| Axsome Therapeutics, Inc. | 2 | $113 |
| ARRAY BIOPHARMA INC | 6 | $98 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $87 |
Products named: BREZTRI, LYBALVI, NURTEC ODT, REXULTI, OTEZLA, CAPLYTA, REPATHA, QULIPTA.
Industry payments across UT — which companies pay providers there.
